MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) reached an understanding with its second-largest shareholder, Jorey Chernett, that could give him a role in shaping the medical technology company’s board while …
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.